Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease.
about
Novel therapeutics for Alzheimer's disease: an updateNeurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidenceHuman genetics of diabetic vascular complicationsNeuroimaging of cerebrovascular disease in the aging brain.Altered cerebral hemodynamics in early Alzheimer disease: a pilot study using transcranial DopplerMitochondrial DNA variants in the pathogenesis of type 2 diabetes - relevance of asian population studies.Application of calibrated fMRI in Alzheimer's disease.Update on the pharmacological treatment of Alzheimer's diseaseNADPH oxidase 1, a novel molecular source of ROS in hippocampal neuronal death in vascular dementia.Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.Frontiers in Alzheimer's disease therapeutics.Phenotypic profiles and functional genomics in Alzheimer's disease and in dementia with a vascular component.Genomic characterization of Alzheimer's disease and genotype-related phenotypic analysis of biological markers in dementia.Neuroprotective effects of L-carnitine against oxygen-glucose deprivation in rat primary cortical neuronsCholesterol and 24S-hydroxycholesterol trafficking in Alzheimer's disease.Bilateral common carotid artery stenosis in normotensive rats impairs endothelium-dependent dilation of parenchymal arteriolesFlavanols, mild cognitive impairment, and Alzheimer's dementia.The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease.Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapiesGetting the iron out: phlebotomy for Alzheimer's disease?ALS and oxidative stress: the neurovascular scenarioInsights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulationModifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia.Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats.The GRK2 Overexpression Is a Primary Hallmark of Mitochondrial Lesions during Early Alzheimer Disease.Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases.The role of inflammatory processes in Alzheimer's disease.The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD.Link between cancer and Alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA overproliferation and deletionHuman genetics of diabetic retinopathy.Human genetics of diabetic nephropathy.Is Vasomotion in Cerebral Arteries Impaired in Alzheimer's Disease?Neurovascular Unit Dysfunction and Blood-Brain Barrier Hyperpermeability Contribute to Schizophrenia Neurobiology: A Theoretical Integration of Clinical and Experimental Evidence.Oxidative Stress Induced Mitochondrial Failure and Vascular Hypoperfusion as a Key Initiator for the Development of Alzheimer Disease.Topiramate Confers Neuroprotection Against Methylphenidate-Induced Neurodegeneration in Dentate Gyrus and CA1 Regions of Hippocampus via CREB/BDNF Pathway in Rats.Expression and Processing of Amyloid Precursor Protein in Vascular Endothelium.Prenatal stress-induced increases in hippocampal von Willebrand factor expression are prevented by concurrent prenatal escitalopram.Sleep mediates the association between homocysteine and oxidative status in mild cognitive impairment.Age-related Impairment of Vascular Structure and Functions
P2860
Q24620383-7D8CCBF0-3D01-4F01-86ED-74E29B4E58E6Q26999061-EBAF7B23-F774-4AE9-8C7F-C016E50EC8D4Q27000709-C6596D42-DCD1-4044-8978-34B5398EC704Q30460557-924B5DBB-602E-4739-910C-3644DD32733BQ30473135-6DF29B0F-E540-498C-9641-3338E80D216DQ33718097-6968D264-6D03-45E2-8B19-F2AFAFFBDE1FQ33726147-9889BD22-8DBA-4BAA-A4D7-CA127093A299Q33836947-C8BA3744-8160-4FA7-B069-B510EE9B015EQ33860500-FD63C810-4911-4BD6-8350-85A613F24B7EQ34333921-A8D84D1E-486A-4F6F-A835-32154CC3D821Q35086876-B2890A64-C074-4F60-9CB7-433E37D69076Q35841700-C5DB3D54-DA2D-4052-A4C9-433A388F6169Q35976397-2BEA9421-AB26-4EAF-A370-F5C22A767B7DQ36116907-7FD95685-7661-4AD9-AEBA-A5D876B58AD7Q36492343-05B230AE-5037-4897-A983-EBE7E928FB34Q36975950-7F6F9E5E-B33F-4871-89B5-A1C8B656F57AQ37000143-1F33ABC2-743F-48A7-9FC0-2028194A16D4Q37268700-AEAF2EA1-243D-4B01-A1BB-A8785FDFC5F1Q37308961-FF23AC62-EF65-4C22-982D-76005361E3AFQ37319051-F65E5359-A825-4054-A61E-A788E1D0B426Q37400451-D6D59E11-B589-4BD0-9EC4-739C441A5B3FQ37416728-BD629AE7-70B1-41D2-8CA8-6D3E42752E0CQ37436616-745C7207-B7DD-4F7F-A4F7-AB85D92D3B84Q37465606-66E51A94-A664-4D92-9DEC-C7839E556F42Q37702799-E742B0AE-475C-4872-B8E8-6A5422045ED3Q37812906-F9C7123B-B9D8-468D-A1B3-268A53DE5568Q37890058-D94E25F7-BCE4-4D4D-B280-6B8FE1FB3D68Q38005630-1381099F-543F-489C-BB75-64A1566B1BA5Q38094984-E9449187-961A-4C1D-B532-9D5EEF7B7BE4Q38108308-663155FE-1B05-4489-A80C-C03385400AFAQ38247113-CDF92F9B-227B-492F-A918-D9651FA8FC67Q38320756-AAE6A2DE-896C-4A06-B1AE-B8CEBBF8D1B4Q38365567-BA132AB4-70AB-49E7-B682-760AE6E57DD1Q38739624-58C59154-88BA-428C-BE0B-24695B39C22DQ38818702-6381279D-3A23-4021-A24A-2B4F9EDAA120Q39025686-DE54DC4D-0356-4DD1-9967-F55627E1B197Q39032252-2303DF50-D3E7-4E81-B1CA-6955DEEAACB7Q39596644-C06BCF5E-EB71-47D6-8FD8-1736A6368480Q41353649-DCDC42F0-61CA-436F-97EC-E5B1B319C111Q41880235-48CD7D67-DF1B-4424-8229-9D0D77E2A756
P2860
Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Role of vascular hypoperfusion ...... hogenesis of Azheimer disease.
@ast
Role of vascular hypoperfusion ...... hogenesis of Azheimer disease.
@en
type
label
Role of vascular hypoperfusion ...... hogenesis of Azheimer disease.
@ast
Role of vascular hypoperfusion ...... hogenesis of Azheimer disease.
@en
prefLabel
Role of vascular hypoperfusion ...... hogenesis of Azheimer disease.
@ast
Role of vascular hypoperfusion ...... hogenesis of Azheimer disease.
@en
P2093
P2860
P356
P1476
Role of vascular hypoperfusion ...... hogenesis of Azheimer disease.
@en
P2093
Gjumrakch Aliev
Jack C de la Torre
Mark E Obrenovich
P2860
P2888
P304
P356
10.1007/BF03033159
P577
2003-01-01T00:00:00Z